This analysis explores what the time needed to harden, and time needed to degrade is of a PLGA bead, as well as whether the size of the needle injecting the bead and the addition of a drug (Vismodegib) may affect these variables. Polymer degradation and hardening are critical to understand for the polymer’s use in clinical settings, as these factors help determine the patients’ and healthcare providers’ use of the drug and estimated treatment time. Based on the literature, it is expected that the natural logarithmic polymer mass degradation forms a linear relationship to time. Polymer hardening was tested by taking video recordings of gelatin plates as they are injected with microneedles and performing RGB analysis on the polymer “beads” created. Our results for the polymer degradation experiments showed that the polymer hardened for all solutions and trials within approximately 1 minute, presenting a small amount of time in which the patient would have to remain motionless in the affected area. Both polymer bead size and drug concentration may have had a modest impact on the hardening time experiments, while bead size may affect the time required for the polymer to degrade. Based on the results, the polymer degradation is expected to last multiple weeks, which may allow for the polymer to be used as a long-term drug delivery system in treatment of basal cell carcinoma.
Sensorimotor adaptation is a type of learning that allows sustaining accurate movements by adjusting motor output. This allows the brain to adapt to temporary changes when engaged in a certain task. Within sensorimotor adaptation, visuomotor adaptation (VMA) is one’s ability to correct a visual perturbation. In this study, we present preliminary results on the effects of VMA with the control group, compared to groups undergoing trigeminal nerve stimulation (TNS) or SHAM (placebo) effects. Twenty-two healthy subjects with no past medical history participated in this study. Subjects performed a visuomotor rotation task, which required gradually adapting to a perturbation between hand motion and corresponding visual feedback. Five total blocks were completed: two familiarization blocks, one baseline block, one rotation block with a 30◦ counterclockwise rotation, and one washout block with no rotation. The control group performed better than the 120 Hz (TNS) and SHAM groups due to less directional error (DE) on the respective learning curves. Additionally, the control group adapted faster (less DE) than the SHAM groups that either felt stimulation, or did not feel the stimulation. The results yield new information regarding VMA which can be used in the future when comparing sensorimotor adaptation and its many applications.
Neuromodulation is an emerging field of research that has a proven therapeutic benefit on a number of neurological disorders, including epilepsy and stroke. It is characterized by using exogenous stimulation to modify neural activity. Prior studies have shown the positive effect of non-invasive trigeminal nerve stimulation (TNS) on motor learning. However, few studies have explored the effect of this specific neuromodulatory method on the underlying physiological processes, including heart rate variability (HRV), facial skin temperatures, skin conductance level, and respiratory rate. Here we present preliminary results of the effects of 3kHz supraorbital TNS on HRV using non-linear (Poincaré plot descriptors) and time-domain (SDNN) measures of analysis. Twenty-one (21) healthy adult subjects were randomly assigned to 2 groups: 3kHz Active stimulation (n=11) and Sham (n=10). Participants’ physiological markers were monitored continuously across three blocks: one ten-minute baseline block, one twenty-minute treatment block, and one ten-minute recovery block. TNS targeting the ophthalmic branches of the trigeminal nerve was delivered during the treatment block for twenty minutes in 30 sec. ON/OFF cycles. The active stimulation group exhibited larger values of all Poincaré descriptors and SDNN during blocks two and three, signifying increased HRV and autonomic nervous system activity.